跳至主要内容
临床试验/ISRCTN36877262
ISRCTN36877262已完成不适用

Clinical study on alternative treatment of patients with second stage Trypanosoma brucei gambiense sleeping sickness

Institute of Tropical Medicine (Belgium)0 个研究点目标入组 600 人开始时间: 2005年12月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1, Older than 15 years
  • 2. Second-stage parasitologically confirmed T. b. gambiense infection
  • 3. Never previously treated for sleeping sickness
  • Second stage disease was defined as: 1° cerebrospinal fluid (CSF) white blood cell (WBC) count >20 /µl and detectable IgM in the CSF; or 2° trypanosomes detected in CSF.

排除标准

  • 1. Glasgow coma scale <8
  • 2. Pregnancy
  • 3. Active tuberculosis
  • 4. Positive syphilis serology
  • 5. Bacterial or cryptococcal meningitis
  • 6. Severe anaemia
  • 7. Severe renal or hepatic dysfunction
  • 8. Hemorrhagic CSF
  • 9. Residence beyond 100 km from Bwamanda Hospital

研究者

发起方
Institute of Tropical Medicine (Belgium)

相似试验

Clinical study on alternative treatment of patients... | 临床试验